Search Results - "Doerflinger, Marcel"

This result is not displayed to guests.
Login for full access.

Successful identification of predictive profiles for infection utilising systems‐level immune analysis: a pilot study in patients with relapsed and refractory multiple myeloma.

Authors: Doerflinger, Marcel Garnham, Alexandra L Freytag, Saskia et al.

Source: Clinical & Translational Immunology. 2021, Vol. 10 Issue 1, p1-10. 10p.

Elucidating novel immune profiles for predicting infection in high‐risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemia.

Authors: Williams, Lewis J Li‐Wai‐Suen, Connie SN Garnham, Alex L et al.

Source: Clinical & Translational Immunology. 2025, Vol. 14 Issue 8, p1-12. 12p.

Mycobacterium ulcerans challenge strain selection for a Buruli ulcer controlled human infection model.

Authors: Muhi, Stephen Buultjens, Andrew H. Porter, Jessica L. et al.

Source: PLoS Neglected Tropical Diseases. 5/3/2024, Vol. 18 Issue 5, p1-25. 25p.

Pseudotumor presentation of CMV disease: Diagnostic dilemma and association with immunomodulating therapy.

Authors: Smibert, Olivia C. Allison, Cody C. Doerflinger, Marcel et al.

Source: Transplant Infectious Disease. Jun2021, Vol. 23 Issue 3, p1-9. 9p.

Metabolic modeling elucidates phenformin and atpenin A5 as broad-spectrum antiviral drugs against RNA viruses.

Authors: Renz, Alina Hohner, Mirjam Jami, Raphaël et al.

Source: Communications Biology. 5/23/2025, Vol. 8 Issue 1, p1-19. 19p.

Current State of Therapeutics for HTLV-1.

Authors: Wang, Tiana T. Hirons, Ashley Doerflinger, Marcel et al.

Source: Viruses (1999-4915). Oct2024, Vol. 16 Issue 10, p1616. 40p.

Circulating BiP/Grp78 is a novel prognostic marker for sepsis‐mediated immune cell death.

Authors: Doerflinger, Marcel Reljic, Boris Menassa, Joseph et al.

Source: FEBS Journal. Mar2021, Vol. 288 Issue 6, p1809-1821. 13p.

This result is not displayed to guests.
Login for full access.

Blood transcriptomics identifies immune signatures indicative of infectious complications in childhood cancer patients with febrile neutropenia.

Authors: Haeusler, Gabrielle M Garnham, Alexandra L Li‐Wai‐Suen, Connie SN et al.

Source: Clinical & Translational Immunology. 2022, Vol. 11 Issue 5, p1-14. 14p.

BH3-only proteins: a 20-year stock-take.

Authors: Doerflinger, Marcel Glab, Jason A. Puthalakath, Hamsa

Source: FEBS Journal. Mar2015, Vol. 282 Issue 6, p1006-1016. 11p.

A human model of Buruli ulcer: The case for controlled human infection and considerations for selecting a Mycobacterium ulcerans challenge strain.

Authors: Muhi, Stephen Osowicki, Joshua O'Brien, Daniel et al.

Source: PLoS Neglected Tropical Diseases. 6/29/2023, Vol. 16 Issue 6, p1-17. 17p.

Chemical chaperone TUDCA prevents apoptosis and improves survival during polymicrobial sepsis in mice.

Authors: Doerflinger, Marcel Glab, Jason Nedeva, Christina et al.

Source: Scientific Reports. 10/7/2016, p34702. 1p.

Alendronate Augments Lipid A-Induced IL-1α Release via Activation of ASC but Not Caspase-11.

Authors: Tamai R Mashima I Kiyoura Y

Source: Inflammation [Inflammation] 2021 Oct; Vol. 44 (5), pp. 2132-2141. Date of Electronic Publication: 2021 Jun 02.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 7600105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2576 (Electronic) Linking ISSN: 03603997 NLM ISO Abbreviation: Inflammation Subsets: MEDLINE